Clinical Development Indication Lead - Rheumatology
argenx
This listing was originally posted on argenx's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Drug products linked to this role
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
The Clinical Development Indication Lead will lead the clinical team for an indication, translating the TPP as set by the Asset Strategy Team into a Clinical Development Plan that answers the relevant questions safeguarding time, quality, and budget. This person will work in close collaboration with the other members of the cross functional team, in order to maximize the potential of the asset for a given indication.
Roles and Responsibilities:
Provide continuous strategic medical insight and planning for the indication during all the stages of development
Own the Clinical development plan and participate in long range strategic planning as data emerges in the indication
Line management of the Global Clinical Trial Physicians working on the indication. Provide coaching and set example for team ensuring high quality medical support for the study teams
Real time oversight of the medical aspects of studies in the indication, including the relevant communication to management as well as the different study teams
Safeguard harmonization across the studies so that communications to external stakeholders ( e.g. questions of IRBs, RAs) are consistent and company efficiency is maintained in close collaboration with peers as well as management of the different functional groups
Lead indication medical ad boards as appropriate
Help build and maintain a “best in class” group of development medical doctors
Ensure compliance of all studies in the indication
Education, Experience and Qualifications:
Medical Doctor with rheumatology specialty education preferred ( other areas such as neurology, dermatology, immunology, internal medicine, pediatric are also of interest)
At least 3-5 years in the pharma/biotech industry, having acquired an in-depth understanding of end to end ( phase I to registration) drug development
Excellent English, both written and spoken is a must, as well as ability to travel
Proven leadership, motivational and interpersonal skills in a global and intercultural environment, including leading through influence
Pro-active problem solver with negotiation skills
Must provide clear vision, direction, and purpose to the different study teams
Demonstrated expertise in clinical trial design, conduct and interpretation of clinical data
Strong communication skills to ensure that study plans and status are transparent, and that risks, issues, and results are clear to all involved parties.
Additional skills in gathering decision information, negotiation and communicating decisions and action
Executes responsibilities with knowledge, accuracy, persistence, resilience and creativity, being an accomplished team player whilst maintaining medical integrity
For applicants in the United States: The annual base salary hiring range for this position is $296,000.00 - $407,000.00 USD. This range reflects our good faith estimate at the time of posting. Individual compensation is determined using objective, inclusive, and job-related criteria such as relevant experience, skills, demonstrated competencies and internal equity. This means actual pay may differ from the posted range when justified by these factors. Because market conditions evolve, pay ranges are reviewed regularly and may be adjusted to remain aligned with external benchmarks.This job is eligible to participate in our short-term and long-term incentive programs, subject to the terms and conditions of those plans and applicable policies. It also includes a comprehensive benefits package, including but not limited to retirement savings plans, health benefits and other benefits subject to the terms of the applicable plans and program guidelines.
At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.
Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at privacy@argenx.com.
If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at hr.us@argenx.com. Only inquiries related to an accommodation request will receive a response.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at argenx?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Antibody therapies
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo